Ratnakar Securities Pvt. Ltd.

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE9930.00-105.75 (-1.05 %)

PREV CLOSE ( ) 10035.75

OPEN PRICE ( ) 10005.00

BID PRICE (QTY) 9929.70 (25)

OFFER PRICE (QTY) 9951.75 (8)

VOLUME 1250

TODAY'S LOW / HIGH ( )9834.50 10045.85

52 WK LOW / HIGH ( )6123 10096.5

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1979

Management Info

Shilpa Divekar Nirula - Chairman Sanjeev Kumar Panchal - Managing Director

Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone 080 6774 8000

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com/india

Registrars Details

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore

Listing : BSE, NSE

NEWS

30May AstraZeneca Pharma gets permission to
AstraZeneca Pharma India has received permission from the Central Drugs..

30May AstraZeneca Pharma soars on getting pe
Astrazeneca Pharma India is currently trading at Rs. 8026.05, up by 107...

30May AstraZeneca Pharma India informs abou
AstraZeneca Pharma India has informed that the company has received perm..

29May Astrazeneca Pharma India receives appr
Astrazeneca Pharma India has received permission from the Central Drugs..

15Apr AstraZeneca Pharma India informs about
AstraZeneca Pharma India has informed that AstraZeneca Pharma India had..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	582.5	1157.4
Gross Profit	784.7	1563.6
Operating Profit	1025.2	2946
Net Sales	4804.8	17162.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE) 5765.00 (2.85%)	M.Cap ( in Cr)25928.90
TTK Healthcare (BSE) 1305.00 (7.14%)	M.Cap ( in Cr)1808.61
Onesource Specialty (BSE) 2012.00 (4.29%)	M.Cap ( in Cr)22984.47
Concord Biotech (BSE) 2086.50 (3.63%)	M.Cap ( in Cr)21062.90
Alkem Laboratories (BSE) 4941.00 (1.37%)	M.Cap ( in Cr)58562.94

Shareholding Pattern

	PROMOTERS	75%
	MUTUAL FUNDS/UTI	4.45%
	NON-INSTITUTION	17.48%
	FI/BANKS/INSURANCE	0.16%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Samco Flexi Cap Fun...	4.54
Bandhan Innovation ...	4.04
Samco ELSS Tax Save...	3.24
Baroda BNP Paribas ...	2.40
DSP Nifty Smallcap2...	1.84
Bandhan Aggressive ...	1.61

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

ASTRAZENECA PHARMA INDIA LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES